141 related articles for article (PubMed ID: 26132195)
1. miR-203 Inhibits Frizzled-2 Expression via CD82/KAI1 Expression in Human Lung Carcinoma Cells.
Mine M; Yamaguchi K; Sugiura T; Chigita S; Yoshihama N; Yoshihama R; Hiyake N; Kobayashi Y; Mori Y
PLoS One; 2015; 10(7):e0131350. PubMed ID: 26132195
[TBL] [Abstract][Full Text] [Related]
2. Anti-miR-362-3p Inhibits Migration and Invasion of Human Gastric Cancer Cells by Its Target CD82.
Zhang QH; Yao YL; Wu XY; Wu JH; Gu T; Chen L; Gu JH; Liu Y; Xu L
Dig Dis Sci; 2015 Jul; 60(7):1967-76. PubMed ID: 25652145
[TBL] [Abstract][Full Text] [Related]
3. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
[TBL] [Abstract][Full Text] [Related]
4. CD82 inhibits canonical Wnt signalling by controlling the cellular distribution of β-catenin in carcinoma cells.
Chigita S; Sugiura T; Abe M; Kobayashi Y; Shimoda M; Onoda M; Shirasuna K
Int J Oncol; 2012 Dec; 41(6):2021-8. PubMed ID: 23076981
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
[TBL] [Abstract][Full Text] [Related]
6. Anti-miR-197 inhibits migration in HCC cells by targeting KAI 1/CD82.
Dai W; Wang C; Wang F; Wang Y; Shen M; Chen K; Cheng P; Zhang Y; Yang J; Zhu R; Zhang H; Li J; Zheng Y; Lu J; Zhou Y; Xu L; Guo C
Biochem Biophys Res Commun; 2014 Apr; 446(2):541-8. PubMed ID: 24613834
[TBL] [Abstract][Full Text] [Related]
7. KAI1/CD82 suppresses hepatocyte growth factor-induced migration of hepatoma cells via upregulation of Sprouty2.
Mu Z; Wang H; Zhang J; Li Q; Wang L; Guo X
Sci China C Life Sci; 2008 Jul; 51(7):648-54. PubMed ID: 18622748
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor-kappaB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53.
Shinohara T; Miki T; Nishimura N; Nokihara H; Hamada H; Mukaida N; Sone S
Cancer Res; 2001 Jan; 61(2):673-8. PubMed ID: 11212267
[TBL] [Abstract][Full Text] [Related]
9. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ
World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of KAI1/CD82 suppresses in vitro cell growth, migration, invasion and xenograft growth in oral cancer.
Chai J; Du L; Ju J; Ma C; Shen Z; Yang X; Liang L; Ni Q; Sun M
Mol Med Rep; 2017 Apr; 15(4):1527-1532. PubMed ID: 28260006
[TBL] [Abstract][Full Text] [Related]
11. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
[TBL] [Abstract][Full Text] [Related]
12. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
Zhou B; Liu L; Reddivari M; Zhang XA
Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
[TBL] [Abstract][Full Text] [Related]
13. Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and β1 integrin activation.
Lee HA; Park I; Byun HJ; Jeoung D; Kim YM; Lee H
Cell Physiol Biochem; 2011; 27(5):575-86. PubMed ID: 21691075
[TBL] [Abstract][Full Text] [Related]
14. HPV-16 E6 promotes cell growth of esophageal cancer via downregulation of miR-125b and activation of Wnt/β-catenin signaling pathway.
Zang B; Huang G; Wang X; Zheng S
Int J Clin Exp Pathol; 2015; 8(10):13687-94. PubMed ID: 26722596
[TBL] [Abstract][Full Text] [Related]
15. Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells.
Jee BK; Lee JY; Lim Y; Lee KH; Jo YH
Biochem Biophys Res Commun; 2007 Aug; 359(3):703-8. PubMed ID: 17560548
[TBL] [Abstract][Full Text] [Related]
16. miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway.
Song L; Liu D; Wang B; He J; Zhang S; Dai Z; Ma X; Wang X
Oncol Rep; 2015 Jul; 34(1):525-31. PubMed ID: 25955111
[TBL] [Abstract][Full Text] [Related]
17. miR-124 represses FZD5 to attenuate P-glycoprotein-mediated chemo-resistance in renal cell carcinoma.
Long QZ; Du YF; Liu XG; Li X; He DL
Tumour Biol; 2015 Sep; 36(9):7017-26. PubMed ID: 25861751
[TBL] [Abstract][Full Text] [Related]
18. BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10.
Gong C; Qu S; Lv XB; Liu B; Tan W; Nie Y; Su F; Liu Q; Yao H; Song E
Nat Commun; 2014 Nov; 5():5406. PubMed ID: 25406648
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.
Jiang N; Chen WJ; Zhang JW; Xu C; Zeng XC; Zhang T; Li Y; Wang GY
Oncotarget; 2015 Apr; 6(10):7866-79. PubMed ID: 25797263
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus inhibits the expression of CD82 through hypermethylation of its promoter in hepatoma cells.
Yu G; Bing Y; Li W; Xia L; Liu Z
Mol Med Rep; 2014 Nov; 10(5):2580-6. PubMed ID: 25119390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
